Making GLP-1 drugs more accessible might seem like a good thing, however the FDA has warned that compounded GLP-1 drugs can be risky for patients
Van Loveren H, Redegeld F, Matsuda H, Buckley T, Teppema JS, & Garssen J (1997) Mast cells
While they do not replace clinical drugs, their affordability, accessibility, and alignment with health-conscious trends make them a valuable addition to the 2025 wellness landscape
BPC-157 is derived from the stomach lining and helps repair the intestinal barrier, thereby reducing chronic inflammation
they are a class of medication that works with your body's natural systems
Semaglutide works by slowing stomach emptying and signaling fullness to the brain, but this mechanism becomes unpredictable and risky at double the prescribed dose